320 related articles for article (PubMed ID: 19061919)
1. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2009 Mar; 198(2):359-65. PubMed ID: 19061919
[TBL] [Abstract][Full Text] [Related]
2. Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867.
Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Jeffrey P; Summerfield S; Rodgers RJ
Behav Brain Res; 2005 Feb; 157(2):331-41. PubMed ID: 15639184
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats.
Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Rodgers RJ
Physiol Behav; 2004 Mar; 81(1):129-40. PubMed ID: 15059692
[TBL] [Abstract][Full Text] [Related]
4. Sibutramine & naloxone: infra-additive interaction in the regulation of appetite?
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2010 Feb; 207(1):174-81. PubMed ID: 19818809
[TBL] [Abstract][Full Text] [Related]
5. Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food.
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2008 Mar; 187(2):417-27. PubMed ID: 18022706
[TBL] [Abstract][Full Text] [Related]
6. Effect of isocaloric diets and sibutramine on food intake, body mass variation and serum TNF-alpha levels in rats.
Trapali M; Liapi C; Perelas A; Perrea D; Stroubini T; Dontas I; Couvari E; Mavri M; Galanopoulou P
Pharmacology; 2008; 82(1):15-21. PubMed ID: 18434760
[TBL] [Abstract][Full Text] [Related]
7. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
Rodgers RJ; Holch P; Tallett AJ
Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921
[TBL] [Abstract][Full Text] [Related]
8. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women.
Halford JC; Boyland EJ; Cooper SJ; Dovey TM; Huda MS; Dourish CT; Dawson GR; Wilding JP
J Psychopharmacol; 2010 Jan; 24(1):99-109. PubMed ID: 18755818
[TBL] [Abstract][Full Text] [Related]
9. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.
Tallett AJ; Blundell JE; Rodgers JR
Behav Pharmacol; 2007 Nov; 18(7):591-600. PubMed ID: 17912043
[TBL] [Abstract][Full Text] [Related]
10. Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S.
Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Rodgers RJ
Behav Brain Res; 2005 May; 160(1):11-24. PubMed ID: 15836896
[TBL] [Abstract][Full Text] [Related]
11. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
Mitchell JE; Gosnell BA; Roerig JL; de Zwaan M; Wonderlich SA; Crosby RD; Burgard MA; Wambach BN
Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
[TBL] [Abstract][Full Text] [Related]
12. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
Van Gaal LF; Wauters MA; De Leeuw IH
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of systemic and central sibutramine administration on the intake of a palatable diet in the rat.
Pratt WE; Connolly ME
Neurosci Lett; 2010 Oct; 484(1):30-4. PubMed ID: 20705119
[TBL] [Abstract][Full Text] [Related]
14. 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
Thomas GH; Babbs AJ; Chatfield RE; Krülle TM; Widdowson PS; Provost D; McCormack JG
Obesity (Silver Spring); 2009 Mar; 17(3):467-73. PubMed ID: 19219064
[TBL] [Abstract][Full Text] [Related]
15. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.
Golozoubova V; Strauss F; Malmlöf K
Pharmacol Biochem Behav; 2006 Apr; 83(4):517-27. PubMed ID: 16647108
[TBL] [Abstract][Full Text] [Related]
16. Regulation of body weight and carcass composition by sibutramine in rats.
Strack AM; Shu J; Camacho R; Gorski JN; Murphy B; MacIntyre DE; Hickey GJ
Obes Res; 2002 Mar; 10(3):173-81. PubMed ID: 11886940
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence.
Halford JC; Lawton CL; Blundell JE
Pharmacol Biochem Behav; 1997 Jan; 56(1):41-6. PubMed ID: 8981607
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
Rowley HL; Butler SA; Prow MR; Dykes SG; Aspley S; Kilpatrick IC; Heal DJ
Synapse; 2000 Nov; 38(2):167-76. PubMed ID: 11018791
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.
Jackson HC; Needham AM; Hutchins LJ; Mazurkiewicz SE; Heal DJ
Br J Pharmacol; 1997 Aug; 121(8):1758-62. PubMed ID: 9283714
[TBL] [Abstract][Full Text] [Related]
20. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
Elfhag K; Finer N; Rössner S
Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
